Proceedings of the International Symposium on Stress and Heart Disease, June 26-29, 1984, Winnipeg, Canada.
First Statement of Responsibility
Robert E Beamish
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Boston
Name of Publisher, Distributor, etc.
Springer US
Date of Publication, Distribution, etc.
1985
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
(441 pages)
GENERAL NOTES
Text of Note
26 ROLE OF THROMBOXANE A2 IN CORONARY VASCULAR DISORDERS.
CONTENTS NOTE
Text of Note
10 INTERACTION OF EPINEPHRINE AND REDUCED EXTRACELLULAR POTASSIUM MAY MEDIATE STRESS-INDUCED VULNERABILITY TO FIBRILLATION IN MAMMALIAN HEART 11 SARCOLEMMAL ALTERATIONS DURING CATECHOLAMINE INDUCED CARDIOMYOPATHYa ; 12 STRESS-INDUCED MOLECULAR CHANGES IN CARDIAC SARCOLEMMA DURING CORONARY ARTERY LIGATION ; 13 VENTRICULAR MYOCARDIUM AS A FAST- OR SLOW-TYPE MUSCLE. THE INFLUENCE OF STRESSORS AND THE PREVENTIVE ACTION OF INTENSE EXERCISE ; 14 EFFECTS OF ADRENERGIC AND ISCHEMIC STRESSES ON MECHANICAL EFFICIENCY OF THE CANINE HEART. 15 HORMONE-INDUCED CHANGES IN RESPONSE TO DRUGS AFFECTING CARDIAC FUNCTION AND METABOLISM. 16 PLASMA CATECHOLAMINE VARIATIONS IN PHYSIOLOGICALLY REACTIVE AND NONREACTIVE INDIVIDUALS TO COLD PRESSOR TEST ; 17 THE EFFECT OF SOME CALCIUM-CHANNEL BLOCKING DRUGS ON THE ENDOGENOUS CATECHOLAMINE CONTENT OF VARIOUS ORGANS OF THE RAT ; C. CATECHOLAMINES-INDUCED CELL DAMAGE ; 18 ROLE OF CATECHOLAMINES IN STRESS-INDUCED HEART DISEASE ; 19 INVOLVEMENT OF CATECHOLAMINES IN THE DEVELOPMENT OF MYOCARDIAL CELL DAMAGE ; 20 MORPHOLOGICAL CORRELATES OF CATECHOLAMINE-INDUCED HEART CELL DAMAGE. 21 THE CONTRIBUTION OF THE ALPHA ADRENOCEPTOR SYSTEM TO THE PATHOGENESIS OF NOREPINEPHRINE CARDIOMYOPATHY* 22 NORADRENALINE INDUCED MYOCARDIOPATHY IN NORMAL AND HYPERCHOLESTEROLAEMIC RHESUS MONKEYS ; 23 LYSOSOMAL CHANGES DURING THE DEVELOPMENT OF CATECHOLAMINE-INDUCED CARDIOMYOPATHY ; 24 THE ADRENOCHROME PATHWAY: ITS POTENTIAL SIGNIFICANCE IN STRESS INDUCED HEART DISEASE ; D. PROSTAGLANDINS AND HEART DISEASE ; 25 THROMBOXANE A2 AND PROSTAGLANDIN I2 AS PRECIPITATING FACTORS OF VASOSPASTIC AND THROMBOTIC EVENTS IN CORONARY ARTERY DISEASE.